跳至主要内容
临床试验/JPRN-UMIN000037433
JPRN-UMIN000037433已完成未知

An observational study of symptomatic adverse events and health-related quality of life (HR-QoL) with the use of patient-reported outcome (PRO) in nivolumab therapy for gastric cancer - NIVO-G QoL Study

St.Marianna University School of Medicine0 个研究点目标入组 30 人开始时间: 2019年7月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 99years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Major Exclusion Criteria: 1.Patients who meet any of the following exclusion criteria will be excluded from this study: 2.Patients who concurrently participate in another detailed PRO study. 3.Patients who apparently have difficulty in evaluating their symptoms by themselves due to a mental condition or cognitive impairment. 4.Patients who apparently have difficulty in using an electronic device for data entry due to a physical disability

研究者

相似试验